Noninvasive differentiation of meningiomas from other brain tumours using combined 111Indium-octreotide/99mtechnetium-DTPA brain scintigraphy

Acta Neurochirurgica

Volumn 138, Issue 10, 1996, Pages 1179-1185

  Barth, A ^a   Haldemann, A R ^a   Reubi, J C ^b   Godoy, N ^a   Rosler H ^a   Kinser, J A ^a   Seiler, R W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

111In DTPA D Phe1 octreotide; Brain tumour; Meningioma; Somatostatin receptors

Indexed keywords

PENTETATE TECHNETIUM TC 99M; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN METASTASIS; BRAIN SCINTISCANNING; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENINGIOMA; NEURILEMOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR DIFFERENTIATION; TUMOR SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; OCTREOTIDE; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M PENTETATE;

EID: 0029959602     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01809748     Document Type: Article

References (26)

1. Bihl H, Dörr U (1993) Somatostatin receptor imaging. Hor Met Res [Suppl] 27: 1-62
2. Ell PJ, Britton KE (1991) The brain. In: Maisey MN, Brition KE, Gilday DL (eds) Clinical nuclear medicine. Chapman & Hall, London, pp 158-197
3. Haldemann AR, Rösler H, Barth A, Waser B, Geiger L, Godoy N, Markwalder RV, Seiler RW, Sulzer M. Reubi JC (1995) Somatostatin receptor scintigraphy in central nervous system tumours: role of blood-brain barrier permeability. J Nucl Med 36: 403-410
4. Hermanz-Schulman M, Welch K, Strand R. Ordia JI (1986) Acoustic neuromas in children. AJNR 7: 519-521
5. 111Indium (DTPA-Octreotide)-scintigraphy in meningioma patients. Acta Neurochir (Wien) 126: 63-71
6. Horie Y, Akagi S, Taguchi K, Yoshino T, Hayashi K, Takahashi K, Akagi T (1990) Malignant schwannoma arising in the intracranial trigeminal nerve. Acta Pathol Jpn 40: 219-225
7. Koper JW, Markstein R, Kohler C, Kwekkeboom DJ, Avezaat CJJ, Lamberts SWJ. Reubi JC (1992) Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 74: 543-547
8. Krenning EP, Bakker WH, Breeman WAP, Koper JW, Kooij PP, Ausema L, Lameris JS, Reubi JC, Lamberts SWJ (1989) Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet i: 242-244
9. Krenning EP, Bakker WH, Kooij PPM, et al (1992) Somatostatin receptor scintigraphy with Indium-111-DTPA-Phe-1-octreotide in man: metabolism, dosimetry and comparison with Iodine-123-Tyr-3-octreotide. J Nucl Med 33: 652-658
10. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20: 716-731
11. Lamberts SWJ, Krenning EP, Reuhi JC (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12: 450-482
12. 111In-DTPA-D-Phe-1-octreotide. Nucl Med Comm 14: 550-558
13. 111In-octrotide. Nucl Med Comm 16: 756-766
14. Moertel CL, Reuhi JC, Scheithauer BS, Scahid DJ, Kvols LK (1994) Expression of somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol 102: 752-756
15. Moyse E, Le Dafniet M, Epelbaum J, Pagesy P, Peillon F, Kordion C, Enjalbert A (1985) Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas. J Clin Endocrinol Metab 61: 98-103
16. Müller HL, Frühwald M, Rendt J, Warmuth-Mertz M, Reubi JC, Kühl J (1995) Somatostatin receptor scintigraphy (SSRS) and somatostatin receptor autoradiography (SSRA) on tumor tissues from children with malignant brain tumors [Abstract]. Eur Soc Pediatr Endocr, Edinburgh (in press)
17. Reubi JC, Horisberger U, Lang W, Koper JW, Braakman R, Lamberts SWJ (1989) Coincidence of EDF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol 134: 337-344
18. Reubi JC, Landolt AM (1984) High density of somatostatin receptors in pituitary tumors from acromegalic patients. J Clin Endocrinol Metab 59: 1148-1151
19. Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SWJ (1987) Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 47: 5758-5764
20. Reubi JC, Maurer R, Klijn JGM, Stefanko SZ, Foekens JA, Blaauw G, Blankenstein MA, Lamberts SWJ (1986) High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab 63: 433-438
21. Rubi JC, Maurer R, von Werder K, Torhorst J, Klijn JGM, Lamberts SWJ (1987) Somatostalin receptors in human endocrine tumors. Cancer Res 47: 551-558
22. Reubi JC, Schaer JC, Waser B, Mengod G (1994) Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumours using in situ hybridization. Cancer Res 54: 3455-3459
23. Reubi JC, Waser B, Vanhagen M, Lamberts SWJ, Krenning EP, Gebbers JO, Laissue JA (1992) In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 50: 895-900
24. Riccabona G (1994) Brain tumor scanning revisited in 1994. Nucl Med Comm 15: 125-127
25. Schober R, Vogeley KT, Urich H, Hölzle E, Wechsler W (1992) Vascular permeability changes in tumours of the peripheral nervous system. Virchous Archiv A Pathol Anat 420: 59-64
26. van Hagen PM, Krenning EP, Reubi JC, Mulder AH, Bakker WH, Oei HY, Löwenberg B, Lamberts SWJ (1993) Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematol 83: 75-79